Delivery Order SPE2DB20D1109-SPE2DB22FN00H
Award Date 11/1/21
Potential Completion Date 11/2/21
Potential Value $2.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Buprenorphine 20 mcg/hr Patches to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with no set-aside designation, indicating open competition. The contract has a ceiling value of $2,519.08 and an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Buprenorphine 20 MCG/HR Patch 4S. The $1,946.84 firm fixed-price contract has a completion date of June 21, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Buprenorphine 15 MCG/HR Patch 4S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,162.20 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 19, 2025, with a period of performance through February 20, 2025. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Buprenorphine 10 MCG/HR Patch 4S, a medication used for pain management. The contract, valued at $1,968.62, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the Defense Logistics Agency (DLA) Troop Support Medical, valued at up...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,535.19, is for the delivery of Buprenorphine 20 MCG/HR Patch 4S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of October 27, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Buprenorphine 20 mcg/hr patches. The $1,033.34 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) and has a completion date of September 26, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of BUPRENORPHINE 20 MCG/HR PATCH 4S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 17, 2024 with a ceiling value of $1,211.98. The contract is a Delivery Order under a Firm Fixed Price arrangement and has an ultimate completion date of October 18, 2024. This award is not designated as a set-aside...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the delivery of Buprenorphine 20 mcg/hr Patch 4s, a specialty pharmaceutical product. The contract, valued at $1,060.77, has an ultimate completion date of April 21, 2023. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award SPE2DB20D1109|SPE2DB23FP08V was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,255.16 firm fixed-price delivery order is for the supply of 4560861778 BUPRENORPHINE 10 MCG/HR PATCH 4S, a medication used for pain management. The contract has an ultimate completion date of May 9, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $1,211.02 to supply Buprenorphine 20 mcg/hr patches. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by November 15, 2023. No set-aside designation was applied to this award made against an existing DLA contract vehicle. Amerisourcebergen provides pharmaceuticals and medical...